The recommendations include internationally accepted definitions of terminology, greater transparency with the public, and stronger biorisk-management systems and oversight.
COVID vaccine ordering changes on August 3, the US destroys its last chemical weapons, and Mandy Cohen takes the CDC reins.
The low incidence of pathogens with bioterrorism potential would hamper efforts to isolate them from natural sources for intentional release, the authors say.
Opening of the NBAF in Kansas marks the culmination of an effort since 2006 to replace the 68-year-old Plum Island Animal Disease Facility in New York.
In the lab breach, virus was detected in a sewage sample and was genetically similar to vaccine stocks used at the facility, then a lab worker tested positive.
The NSABB endorses findings from two of its working groups, one on oversight of potential pandemic pathogens and the other on dual-use research of concern.
Draft recommendations from a panel that advises the NIH would tighten oversight of potentially dangerous pathogens.
Work on a hybrid SARS-CoV-2 virus has inflamed more controversy about lab biosafety and federal oversight
Biopharmaceutical company Spero Therapeutics announced today that it has entered into a licensing agreement with GSK for the antibiotic tebipenem pivoxil hydrobromide (HBr).
A retrospective study of 17 COVID-19 survivors with lingering symptoms reveals that 10 (59%) had nerve damage, which the researchers said could have been triggered by potentially treatable infection-related immune dysfunction.
